CASE 11384 Published on 27.12.2013

Idiopathic Hypereosinophilic Syndrome manifest with Deep Vein Thrombosis and Pulmonary Embolism

Section

Chest imaging

Case Type

Clinical Cases

Authors

Theodorou DJ, Theodorou SJ, Pallada S, Mantzoukis F, Tzimas T, Batsoulis A, Mastora M, Akritidis N.

Gen. Hospital of Ioannina & National Healthcare System, Radiology; 13 Papadopoulos street 45444 Ioannina, Greece; Email:daphne_theodorou@hotmail.com
Patient

39 years, male

Categories
Area of Interest Lung ; Imaging Technique Digital radiography, CT, CT-Angiography
Clinical History
Patient presented with abdominal pain and fever (38.2 ˚C). Medical history was insignificant. Laboratory tests showed elevated leukocyte count:13, 170/mm [3] with 43% eosinophils, 0.1% basophils, and decreased platelet count: 55, 000/mm [3]. Erythrocyte sedimentation rate and C-reactive protein level were elevated. On the second hospital day, he experienced left leg swelling.
Imaging Findings
Chest radiograph showed bilateral patchy opacities, in middle and lower zones, with no clear pattern of distribution (Fig.1). There was no pleural effusion. Axial chest CT scan revealed peripheral left upper lobe infiltrates (arrowheads) and right upper lobe ground-glass opacity (asterisk) tending towards consolidation (Fig. 2). Lower extremity venous ultrasonography revealed thrombosis of the common and superficial femoral veins as well as the popliteal vein. In addition, CT pulmonary angiogram revealed an intraluminal filling defect in the right main pulmonary artery, consistent with pulmonary thrombus (Fig. 3).
Discussion
Idiopathic Hypereosinophilic Syndrome (IHS), a rare disorder, has been defined as persistent idiopathic eosinophilia greater than 1500 cells/mm [3] for more than 6 months or death within 6 months; absence of parasitic, allergic, or other known causes of eosinophilia; and signs or symptoms of organ damage related to eosinophilic infiltration [1]. Onset usually occurs in the third or fourth decade of life, with a male-female ratio of 7:1 [2].
Cardiac involvement including mural thrombosis, endocardial fibrosis, which may lead to restrictive cardiomyopathy is the major cause of morbidity and mortality in IHS [2]. Pulmonary involvement is observed in 40% of patients. Pleural effusion is seen in 50% of affected patients [3, 4]. Thromboembolic disease, peripheral neuropathy, and involvement of the GI tract, kidneys, joints, and skin have also been reported [1, 2]. Although biopsy is generally not required for the diagnosis of IHS, histopathologic analysis demonstrates eosinophilic infiltration of involved organs with associated disruption of organ architecture and necrosis [2].
Radiographic findings in IHS are often non-specific and consist of focal or diffuse interstitial or alveolar non-lobar opacities, with most pulmonary opacities being related to severe cardiac failure, although lesions from the eosinophilia itself may be seen [1]. CT shows single or multiple nodules with or without surrounding ground-glass opacity and focal or diffuse areas of ground-glass opacity or interstitial infiltrates.
Treatment of IHS is empirical based on systemic corticosteroids. Currently, there are no randomised controlled trials to establish dosing regimens. Our patient was treated with per os prednisone (25 mg four times a day) and subcutaneous heparin. Clinical improvement was rapid, with normalisation of body temperature within four days after initiation of treatment. Lung infiltrates subsided and he was discharged on the eighth hospital day. Prednisone dose was tapered down over the next eight weeks. There was no recurrence of symptoms during tapering of steroids, or upon discontinuation of therapy at a 2-year follow-up.
Differential Diagnosis List
Idiopathic Hypereosinophilic Syndrome
Infectious diseases (invasive pulmonary aspergillosis
Mucormycosis
Candidiasis
Wegener granulomatosis
Primary and metastatic hemorrhagic tumors
Bronchioloalveolar carcinoma
Pulmonary lymphoma
Final Diagnosis
Idiopathic Hypereosinophilic Syndrome
Case information
URL: https://www.eurorad.org/case/11384
DOI: 10.1594/EURORAD/CASE.11384
ISSN: 1563-4086